Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

RSS icon
Kendra Grubb discusses TAVR vs SAVR and the most recent data to explain choices with patients.

TAVR or SAVR? Where things stand now, from a surgeon's perspective

Kendra Grubb, MD, one of the country's leading experts on cardiac surgery, discussed what she tells her patients when they ask if TAVR is better than SAVR for treating severe aortic stenosis. 

Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.

IVUS-guided PCI boosts 2-year survival, reduces need for bypass surgery

IVUS was especially effective when treating patients with a complex coronary anatomy, researchers found. 

Thumbnail

IVL gains higher level of reimbursement with one of biggest coding updates for PCI in decades

Intravascular lithotripsy therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1.

df

‘More dangerous than useful’: 1 in 5 coronary stents implanted by cardiologists are unnecessary, wasting $800M per year

A cardiologist-led think tank tracked data from more than 1 million procedures, exploring the clinical and economic impacts of implanting low-value coronary stents. 

Robert Yeh, MD, explains the details of the AGENT IDE trial clinical trial results for the Agent drug-coated balloon vs plain angioplasty for in-stent restenosis at TCT 2023. #TCT #TCT2023 #DCB

Coronary drug-coated balloon superior to standard of care for in-stent restenosis

Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis. 

Ziad Ali, MD, explains the ILUMIEN IV trial results for OCT Vs. Angiography.

ILUMIEN IV: OCT adds value over angiography alone, fails to improve outcomes

Ziad Ali, MD, discusses the mixed results of the ILUMIEN IV trial comparing OCT vs angiography alone.

Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.

Ken Rosenfield, MD, Mass General Hospital, explains the impact wider CMS reimbursement for carotid artery stenting will have on patient stroke care and interventional cardiology. CAS

Q&A: Ken Rosenfield explains the impact of new reimbursement coverage for carotid stenting 

Ken Rosenfield, MD, helped spearhead the recent Medicare policy change that made carotid stenting procedures available to more patients.

Displaying 81 - 88 of 439
Design by Adaptive Theme